Wondfo 2019-nCoV Antigen Test Got Registration Certificate

On November 3, Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) obtained the NMPA registration certificate.

Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) delivers reliable test results in 20 minutes. It can quickly detect positive cases during the acute phase of the infection when the virus load is high, ideal for applications to the early clinical classification and efficient management of suspected patients.

The antigen test can be used as an aid in the diagnosis of COVID-19. It should not be used as the sole basis to diagnose COVID-19. 

The test result shall be comprehensively interpreted by combining results of the nucleic acid test and imaging examination, as well as the patient’s medical history and previous contacts. And both the positive and negative antigen test results of suspected patients shall be further confirmed by the nucleic acid test.

The approval of Wondfo 2019-nCoV Antigen Test leads to the increased types and supply of COVID-19 tests, better satisfying the global demands for on-spot rapid diagnosis of COVID-19. The test is about to infuse strong power to the prevention and control of the pandemic.